NCT05427669: Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)
- State
- Not started
- Phase
- Phase 3
- People
- 340 planned
- Started
- 9 Oct 2022
- Primary completion
- 1 Jul 2025
- Arms
- mFOLFOXIRI
- Results
- None posted
- 22 Jun 2022: Trial registered